Current pricing levels (~USD 900/month) keep adoption in single digits, but every halving of net price can nearly double penetration, provided supply and prescriber infrastructure are stable
Clinical trials conducted by Eli Lilly, the manufacturer of tirzepatide, found that fatigue affects approximately 5% of people taking the 5mg dose, 6% on the 10mg dose, and 7% on the 15mg dose
However, for patients with contraindications or intolerance to incretin-based therapy, continued use of basal insulin may remain the safer choice
That is a precise claim rather than a sweeping one, and it is one the research actually supports
UK patients can search for active retatrutide studies via the NIHR 'Be Part of Research' website (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov
PWA mice were administered with equimolar doses of GLP1, E, or GLP1/E (10 nmol/kg), and results were compared with those of vehicle- or metformin-treated (300 mg/kg) PWA mice